BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porter-Stransky KA, Weinshenker D. Arresting the Development of Addiction: The Role of β-Arrestin 2 in Drug Abuse. J Pharmacol Exp Ther 2017;361:341-8. [PMID: 28302862 DOI: 10.1124/jpet.117.240622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Fonseca F, Torrens M. Pharmacogenetics of Methadone Response. Mol Diagn Ther 2018;22:57-78. [DOI: 10.1007/s40291-017-0311-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Meinhardt MW, Giannone F, Hirth N, Bartsch D, Spampinato SM, Kelsch W, Spanagel R, Sommer WH, Hansson AC. Disrupted circadian expression of beta-arrestin 2 affects reward-related µ-opioid receptor function in alcohol dependence. J Neurochem 2021. [PMID: 34919270 DOI: 10.1111/jnc.15559] [Reference Citation Analysis]
3 Jiang MP, Xu C, Guo YW, Luo QJ, Li L, Liu HL, Jiang J, Chen HX, Wei XQ. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice. World J Gastroenterol 2018; 24(2): 216-225 [PMID: 29375207 DOI: 10.3748/wjg.v24.i2.216] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
4 Mazahery C, Benson BL, Cruz-Lebrón A, Levine AD. Chronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli. J Immunol 2020;204:1188-200. [PMID: 31969385 DOI: 10.4049/jimmunol.1900862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Crawford CA, Teran A, Ramirez GI, Katz CG, Mohd-Yusof A, Eaton SE, Real V, McDougall SA. Age-dependent effects of dopamine receptor inactivation on cocaine-induced behaviors in male rats: Evidence of dorsal striatal D2 receptor supersensitivity. J Neurosci Res 2019;97:1546-58. [PMID: 31304635 DOI: 10.1002/jnr.24491] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Veerappa A, Pendyala G, Guda C. A systems omics-based approach to decode substance use disorders and neuroadaptations. Neurosci Biobehav Rev 2021;130:61-80. [PMID: 34411560 DOI: 10.1016/j.neubiorev.2021.08.016] [Reference Citation Analysis]
7 Duerrauer L, Muratspahić E, Gattringer J, Keov P, Mendel HC, Pfleger KDG, Muttenthaler M, Gruber CW. I8-arachnotocin-an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor. Sci Rep 2019;9:19295. [PMID: 31848378 DOI: 10.1038/s41598-019-55675-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alexander RA, Lot I, Enslen H. Methods to Characterize Protein Interactions with β-Arrestin In Cellulo. In: Scott MGH, Laporte SA, editors. Beta-Arrestins. New York: Springer; 2019. pp. 139-58. [DOI: 10.1007/978-1-4939-9158-7_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Hansen W, Luppus S, Barthel R, Chang DI, Broemstrup J, Zwarg T, Shibata J, Westendorf AM, Buer J, Scherbaum N. Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4+ T cell proliferation. Addict Biol 2021;26:e12998. [PMID: 33336491 DOI: 10.1111/adb.12998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mittal N, Minasyan A, Romaneschi N, Hakimian JK, Gonzalez-Fernandez G, Albert R, Desai N, Mendez IA, Schallert T, Ostlund SB, Walwyn W. Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function. PLoS One 2017;12:e0185796. [PMID: 28973019 DOI: 10.1371/journal.pone.0185796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Slosky LM, Bai Y, Toth K, Ray C, Rochelle LK, Badea A, Chandrasekhar R, Pogorelov VM, Abraham DM, Atluri N, Peddibhotla S, Hedrick MP, Hershberger P, Maloney P, Yuan H, Li Z, Wetsel WC, Pinkerton AB, Barak LS, Caron MG. β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors. Cell 2020;181:1364-1379.e14. [PMID: 32470395 DOI: 10.1016/j.cell.2020.04.053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
12 Han F, Konkalmatt P, Mokashi C, Kumar M, Zhang Y, Ko A, Farino ZJ, Asico LD, Xu G, Gildea J, Zheng X, Felder RA, Lee REC, Jose PA, Freyberg Z, Armando I. Dopamine D2 receptor modulates Wnt expression and control of cell proliferation. Sci Rep 2019;9:16861. [PMID: 31727925 DOI: 10.1038/s41598-019-52528-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids. Addict Biol 2020;25:e12823. [PMID: 31441201 DOI: 10.1111/adb.12823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Wang T, Zhu X, Yi H, Gu J, Liu S, Izenwasser S, Lemmon VP, Roy S, Hao S. Viral vector-mediated gene therapy for opioid use disorders. Exp Neurol 2021;341:113710. [PMID: 33781732 DOI: 10.1016/j.expneurol.2021.113710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Karavidha KK, Burmeister M, Greenwald MK. β-Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use. Am J Addict 2021;30:351-7. [PMID: 33783060 DOI: 10.1111/ajad.13150] [Reference Citation Analysis]
16 Smith KE, Bunting AM, Walker R, Hall MT, Grundmann O, Castillo O. Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users. Journal of Psychoactive Drugs 2019;51:311-22. [DOI: 10.1080/02791072.2019.1597224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]